Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Type 1 or 2”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Post-approval studies (Phase 4)Study completedNCT00420095
What this trial is testing

Patients With Diabetes Mellitus (IOPA)

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Eli Lilly and Company 117
Not applicableStudy completedNCT07141940
What this trial is testing

Indonesian-Language Application-Based Guided Imagery Therapy for Insomnia and Glycemic Control in Diabetic Patients

Who this might be right for
Diabetes (Insulin-requiring, Type 1 or Type 2)Insomnia Type; Sleep DisorderFasting Plasma Glucose
Dr Cipto Mangunkusumo General Hospital 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT05608044
What this trial is testing

Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Agenus Inc. 234
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Not applicableNot Yet RecruitingNCT07420972
What this trial is testing

Pilot Study of Intrapartum Insulin Pump

Who this might be right for
DiabetesDiabetes (Insulin-requiring, Type 1 or Type 2)Pregnancy
Medstar Health Research Institute 30
Testing effectiveness (Phase 2)Study completedNCT04663282
What this trial is testing

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 179
Not applicableUnknownNCT02023489
What this trial is testing

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

Who this might be right for
Type 2 Diabetes MellitusPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Familiar Hypocalcuric Hypercalcemia+2 more
Medical University of Vienna 90
Not applicableStudy completedNCT01231984
What this trial is testing

Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Becton, Dickinson and Company 293
Not applicableStudy completedNCT07675161
What this trial is testing

MiniMed Fit Payload Wear Pediatric Study

Who this might be right for
Diabetes (DM)Diabetes (Insulin-requiring, Type 1 or Type 2)Diabetes in Children+1 more
Medtronic MiniMed, Inc. 59
Early research (Phase 1)Study completedNCT00269061
What this trial is testing

Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin

Who this might be right for
Non-Insulin-Dependent Diabetes Mellitus
GlaxoSmithKline 32
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Not applicableStudy completedNCT00671008
What this trial is testing

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 400
Not applicableStudy completedNCT01941290
What this trial is testing

BIOFLOW III Asia Registry Orsiro Stent System

Who this might be right for
Coronary Artery DiseaseMyocardial IschemiaDiabetes Mellitus Type 1 or 2
BIOTRONIK Asia Pacific Pte Ltd 387
Large-scale testing (Phase 3)Study completedNCT00135941
What this trial is testing

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

Who this might be right for
Diabetes Mellitus
Sanofi 582
Post-approval studies (Phase 4)UnknownNCT03444142
What this trial is testing

Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
University of Guadalajara 30
Early research (Phase 1)Study completedNCT00102297
What this trial is testing

Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Kyntra Bio 20
Post-approval studies (Phase 4)Ended earlyNCT00453934
What this trial is testing

Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Valeritas, Inc. 11
Not applicableEnded earlyNCT02080741
What this trial is testing

Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Who this might be right for
Patients With Type 1 or Type 2 DiabetesPatients With a Type A or B Behaviour Profile
Centre Hospitalier Universitaire Dijon 57
Not applicableStudy completedNCT00659295
What this trial is testing

Observational Study to Evaluate the Safety of Levemir® in Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 51,170
Early research (Phase 1)Study completedNCT06615700
What this trial is testing

Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus

Who this might be right for
Overweight or ObesityType 2 Diabetes
Biomed Industries, Inc. 74
Next Page